The Motley Fool··Jonathan PoncianoAdaptive Biotech Insider Sells $554K Stake as Revenue Surges 55%—Here's Why It Matters
Adaptive Biotech insider sold $554K in shares via routine plan; company posted 55% revenue growth and dramatically narrowed losses, signaling operational inflection.
MSFTADPTprofitabilityrevenue growth